The ALPPS procedure for hepatocellular carcinoma

Trends and predictors of outcomes after surgery for hepatocellular carcinoma: A nationwide population-based study in Taiwan

“…4,14e16 National registry studies such as those performed by the Taiwan BNHI are an excellent source of population-based data for evaluating the current practice of HCC surgery. 17,18 Unlike single-center series studies, data from registry studies provide an overview of practices in large populations while avoiding referral bias or bias reflecting the practices of individual physicians or institutions. 19 This analysis of temporal trends in HCC surgery showed that, during 1998e2009, hospital treatment cost increased, but LOS decreased.…”

Laparoscopic and robotic approach for hepatocellular carcinoma—state of the art

“…In very little cases some authors suggest to perform the Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) for HCC. ALPPS procedure has been described with good results with traditional access (45,46). Totally laparoscopic ALPPS is described as feasible but must be performed by experienced hands (47,48).…”

Recent advances in surgical treatment of hepatocellular carcinoma

“…In fact, a cirrhotic liver is less capable for hypertrophy after PVE than is a healthy liver. Vennarecci et al (54) found that i) the ALLPS procedure is technically feasible and safe even when performing a major liver resection to treat HCC in a cirrhotic liver, that ii) the procedure is able to induce a significant increase in the volume of the FLR in a short period of time, allowing completion of the second stage of ALPPS, and that iii) the volume of face the challenge of choosing either resection of the hepatic tumor with a potential risk of postoperative liver failure (PHLF) or giving the patient palliative treatment, such as transcatheter arterial chemoembolization or local ablative therapy, to avoid PHLF if the volume of the FLR is on the borderline (39,40). In recent years, some strategies, such as portal vein ligation (PVL), portal vein embolization (PVE), and two-stage liver resection have been developed to induce hypertrophy of the FLR prior to hepatectomy in primarily non-resectable liver tumors (41).…”